NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors-A Retrospective Molecular Tumor Board Analysis

被引：6

作者：

Gremke, Niklas ^{[1
,2
]}

Rodepeter, Fiona R. ^{[3
]}

Teply-Szymanski, Julia ^{[3
]}

Griewing, Sebastian ^{[1
]}

Boekhoff, Jelena ^{[1
]}

Stroh, Alina ^{[1
,2
]}

Tarawneh, Thomas S. ^{[4
]}

Riera-Knorrenschild, Jorge ^{[4
]}

Balser, Christina ^{[5
]}

Hattesohl, Akira ^{[3
]}

Middeke, Martin ^{[6
]}

Ross, Petra ^{[4
]}

Litmeyer, Anne-Sophie ^{[3
]}

Romey, Marcel ^{[3
]}

Stiewe, Thorsten ^{[2
]}

Wuendisch, Thomas ^{[6
]}

Neubauer, Andreas ^{[4
]}

Denkert, Carsten ^{[3
]}

Wagner, Uwe ^{[1
]}

Mack, Elisabeth K. M. ^{[4
,7
]}

机构：

[1] Philipps Univ, Univ Hosp Giessen & Marburg, Dept Gynecol Gynecol Endocrinol & Oncol, Campus Marburg, D-35043 Marburg, Germany

[2] Philipps Univ, Inst Mol Oncol, D-35043 Marburg, Germany

[3] Philipps Univ, Univ Hosp Giessen & Marburg, Inst Pathol, Campus Marburg, D-35043 Marburg, Germany

[4] Philipps Univ, Univ Hosp Giessen & Marburg, Dept Hematol Oncol & Immunol, Campus Marburg, D-35043 Marburg, Germany

[5] Practice Internal Med Hematol & Internal Oncol, D-35043 Marburg, Germany

[6] Philipps Univ, Univ Hosp Giessen & Marburg, Comprehens Canc Ctr Marburg, Campus Marburg, D-35043 Marburg, Germany

[7] St Marien Hosp Siegen, Dept Hematol Med Oncol & Palliat Med, Siegen, Germany

来源：

CANCERS | 2024年 / 16卷 / 08期

关键词：

precision oncology; next-generation sequencing; breast cancer; gynecological tumors; molecular tumor board; OLAPARIB MAINTENANCE THERAPY; AMERICAN-SOCIETY; MEDICINE; RECOMMENDATIONS; PEMBROLIZUMAB; DIAGNOSTICS; EXPERIENCE; GENOMICS; COLLEGE;

D O I：

10.3390/cancers16081561

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Simple Summary Identifying the mutational landscape of tumors using next-generation sequencing (NGS) has become substantially more common over the past decade, especially in patients with advanced tumors. However, there is still limited real-world evidence for the clinical benefits of NGS-guided precision oncology. This retrospective analysis of breast and gynecological cancer patients referred to our center's multidisciplinary Molecular Tumor Board revealed that treatment recommendations were provided to 63.3% of patients, of whom 29.1% received molecular-matched treatment resulting in significantly prolonged progression-free survival. Commonly altered genes included TP53, PIK3CA, BRCA1/2, and ARID1A. Overall, NGS-guided precision oncology using panel diagnostics demonstrated improved clinical outcomes in a subset of patients with breast and gynecological cancers in a real-world setting.Abstract Background: Precision oncology treatments are being applied more commonly in breast and gynecological oncology through the implementation of Molecular Tumor Boards (MTBs), but real-world clinical outcome data remain limited. Methods: A retrospective analysis was conducted in patients with breast cancer (BC) and gynecological malignancies referred to our center's MTB from 2018 to 2023. The analysis covered patient characteristics, next-generation sequencing (NGS) results, MTB recommendations, therapy received, and clinical outcomes. Results: Sixty-three patients (77.8%) had metastatic disease, and forty-four patients (54.3%) had previously undergone three or more lines of systemic treatment. Personalized treatment recommendations were provided to 50 patients (63.3%), while 29 (36.7%) had no actionable target. Ultimately, 23 patients (29.1%) underwent molecular-matched treatment (MMT). Commonly altered genes in patients with pan-gyn tumors (BC and gynecological malignancies) included TP53 (n = 42/81, 51.9%), PIK3CA (n = 18/81, 22.2%), BRCA1/2 (n = 10/81, 12.3%), and ARID1A (n = 9/81, 11.1%). Patients treated with MMT showed significantly prolonged progression-free survival (median PFS 5.5 vs. 3.5 months, p = 0.0014). Of all patients who underwent molecular profiling, 13.6% experienced a major clinical benefit (PFSr >= 1.3 and PR/SD >= 6 months) through precision oncology. Conclusions: NGS-guided precision oncology demonstrated improved clinical outcomes in a subgroup of patients with gynecological and breast cancers.

引用

页数：17

共 68 条

[1] Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative [J].

Aftimos, Philippe ;

Oliveira, Mafalda ;

Irrthum, Alexandre ;

Fumagalli, Debora ;

Sotiriou, Christos ;

Gal-Yam, Einav Nili ;

Robson, Mark E. ;

Ndozeng, Justin ;

Di Leo, Angelo ;

Ciruelos, Eva M. ;

de Azambuja, Evandro ;

Viale, Giuseppe ;

Scheepers, Elsemieke D. ;

Curigliano, Giuseppe ;

Bliss, Judith M. ;

Reis-Filho, Jorge S. ;

Colleoni, Marco ;

Balic, Marija ;

Cardoso, Fatima ;

Albanell, Joan ;

Duhem, Caroline ;

Marreaud, Sandrine ;

Romagnoli, Dario ;

Rojas, Beatriz ;

Gombos, Andrea ;

Wildiers, Hans ;

Guerrero-Zotano, Angel ;

Hall, Peter ;

Bonetti, Andrea ;

Larsson, Karolina Fs ;

Degiorgis, Martina ;

Khodaverdi, Silvia ;

Greil, Richard ;

Sverrisdottir, Asgerdur ;

Paoli, Marta ;

Seyll, Ethel ;

Loibl, Sibylle ;

Linderholm, Barbro ;

Zoppoli, Gabriele ;

Davidson, Nancy E. ;

Johannsson, Oskar Th ;

Bedard, Philippe L. ;

Loi, Sherene ;

Knox, Susan ;

Cameron, David A. ;

Harbeck, Nadia ;

Montoya, Maite Lasa ;

Brandao, Mariana ;

Vingiani, Andrea ;

Caballero, Carmela .

CANCER DISCOVERY, 2021, 11 (11) :2796-2811

[2] Genomics to select treatment for patients with metastatic breast cancer [J].

Andre, Fabrice ;

Filleron, Thomas ;

Kamal, Maud ;

Mosele, Fernanda ;

Arnedos, Monica ;

Dalenc, Florence ;

Sablin, Marie-Paule ;

Campone, Mario ;

Bonnefoi, Herve ;

Lefeuvre-Plesse, Claudia ;

Jacot, William ;

Coussy, Florence ;

Ferrero, Jean-Marc ;

Emile, George ;

Mouret-Reynier, Marie-Ange ;

Thery, Jean-Christophe ;

Isambert, Nicolas ;

Mege, Alice ;

Barthelemy, Philippe ;

You, Benoit ;

Hajjaji, Nawale ;

Lacroix, Ludovic ;

Rouleau, Etienne ;

Tran-Dien, Alicia ;

Boyault, Sandrine ;

Attignon, Valery ;

Gestraud, Pierre ;

Servant, Nicolas ;

Le Tourneau, Christophe ;

Cherif, Linda Larbi ;

Soubeyran, Isabelle ;

Montemurro, Filippo ;

Morel, Alain ;

Lusque, Amelie ;

Jimenez, Marta ;

Jacquet, Alexandra ;

Goncalves, Anthony ;

Bachelot, Thomas ;

Bieche, Ivan .

NATURE, 2022, 610 (7931) :343-+

[3] Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline [J].

Bedrosian, Isabelle ;

Somerfield, Mark R. ;

Achatz, Maria Isabel ;

Boughey, Judy C. ;

Curigliano, Giuseppe ;

Friedman, Sue ;

Kohlmann, Wendy K. ;

Kurian, Allison W. ;

Laronga, Christine ;

Lynce, Filipa ;

Norquist, Barbara S. ;

Plichta, Jennifer K. ;

Rodriguez, Patricia ;

Shah, Payal D. ;

Tischkowitz, Marc ;

Wood, Marie ;

Yadav, Siddhartha ;

Yao, Katherine ;

Robson, Mark E. .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (05) :584-604

[4] A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers [J].

Berger, Ashton C. ;

Korkut, Anil ;

Kanchi, Rupa S. ;

Hegde, Apurva M. ;

Lenoir, Walter ;

Liu, Wenbin ;

Liu, Yuexin ;

Fan, Huihui ;

Shen, Hui ;

Ravikumar, Visweswaran ;

Rao, Arvind ;

Schultz, Andre ;

Li, Xubin ;

Sumazin, Pavel ;

Williams, Cecilia ;

Mestdagh, Pieter ;

Gunaratne, Preethi H. ;

Yau, Christina ;

Bowlby, Reanne ;

Robertson, A. Gordon ;

Tiezzi, Daniel G. ;

Wang, Chen ;

Cherniack, Andrew D. ;

Godwin, Andrew K. ;

Kuderer, Nicole M. ;

Rader, Janet S. ;

Zuna, Rosemary E. ;

Sood, Anil K. ;

Lazar, Alexander J. ;

Ojesina, Akinyemi I. ;

Adebamowo, Clement ;

Adebamowo, Sally N. ;

Baggerly, Keith A. ;

Chen, Ting-Wen ;

Chiu, Hua-Sheng ;

Lefever, Steve ;

Liu, Liang ;

MacKenzie, Karen ;

Orsulic, Sandra ;

Roszik, Jason ;

Shelley, Carl Simon ;

Song, Qianqian ;

Vellano, Christopher P. ;

Wentzensen, Nicolas ;

Weinstein, John N. ;

Mills, Gordon B. ;

Levine, Douglas A. ;

Akbani, Rehan .

CANCER CELL, 2018, 33 (04) :690-+

[5] Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial [J].

Bertucci, Francois ;

Goncalves, Anthony ;

Guille, Arnaud ;

Adelaide, Jose ;

Garnier, Severine ;

Carbuccia, Nadine ;

Billon, Emilien ;

Finetti, Pascal ;

Sfumato, Patrick ;

Monneur, Audrey ;

Pecheux, Christophe ;

Khran, Martin ;

Brunelle, Serge ;

Mescam, Lenaig ;

Thomassin-Piana, Jeanne ;

Poizat, Flora ;

Charafe-Jauffret, Emmanuelle ;

Turrini, Olivier ;

Lambaudie, Eric ;

Provansal, Magali ;

Extra, Jean-Marc ;

Madroszyk, Anne ;

Gilabert, Marine ;

Sabatier, Renaud ;

Vicier, Cecile ;

Mamessier, Emilie ;

Chabannon, Christian ;

Pakradouni, Jihane ;

Viens, Patrice ;

Andre, Fabrice ;

Gravis, Gwenaelle ;

Popovici, Cornel ;

Birnbaum, Daniel ;

Chaffanet, Max .

GENOME MEDICINE, 2021, 13 (01)

[6] Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice [J].

Bruzas, Simona ;

Kuemmel, Sherko ;

Harrach, Hakima ;

Breit, Elisabeth ;

Ataseven, Beyhan ;

Traut, Alexander ;

Rueland, Anna ;

Kostara, Athina ;

Chiari, Ouafaa ;

Dittmer-Grabowski, Christine ;

Reinisch, Mattea .

CANCERS, 2021, 13 (18)

[7] Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery [J].

Bryce, Alan H. ;

Egan, Jan B. ;

Borad, Mitesh J. ;

Stewart, A. Keith ;

Nowakowski, Grzegorz S. ;

Chanan-Khan, Asher ;

Patnaik, Mrinal M. ;

Ansell, Stephen M. ;

Banck, Michaela S. ;

Robinson, Steven I. ;

Mansfield, Aaron S. ;

Klee, Eric W. ;

Oliver, Gavin R. ;

McCormick, Jennifer B. ;

Huneke, Norine E. ;

Tagtow, Colleen M. ;

Jenkins, Robert B. ;

Rumilla, Kandelaria M. ;

Kerr, Sarah E. ;

Kocher, Jean-Pierre A. ;

Beck, Scott A. ;

Fernandez-Zapico, Martin E. ;

Farrugia, Gianrico ;

Lazaridis, Konstantinos N. ;

McWilliams, Robert R. .

ONCOTARGET, 2017, 8 (16) :27145-27154

[8]

Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011

[9] Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine [J].

Charo, Lindsey M. ;

Eskander, Ramez N. ;

Sicklick, Jason ;

Kim, Ki Hwan ;

Lim, Hyo Jeong ;

Okamura, Ryosuke ;

Lee, Suzanna ;

Subramanian, Rupa ;

Schwab, Richard ;

Shatsky, Rebecca ;

Plaxe, Steven ;

Kato, Shumei ;

Kurzrock, Razelle .

JCO PRECISION ONCOLOGY, 2022, 6

[10] Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Coleman, Robert L. ;

Oza, Amit M. ;

Lorusso, Domenico ;

Aghajanian, Carol ;

Oaknin, Ana ;

Dean, Andrew ;

Colombo, Nicoletta ;

Weberpals, Johanne, I ;

Clamp, Andrew ;

Scambia, Giovanni ;

Leary, Alexandra ;

Holloway, Robert W. ;

Amenedo Gancedo, Margarita ;

Fong, Peter C. ;

Goh, Jeffrey C. ;

O'Malley, David M. ;

Armstrong, Deborah K. ;

Garcia-Donas, Jesus ;

Swisher, Elizabeth M. ;

Floquet, Anne ;

Konecny, Gottfried E. ;

McNeish, lain A. ;

Scott, Clare L. ;

Cameron, Terri ;

Maloney, Lara ;

Isaacson, Jeff ;

Goble, Sandra ;

Grace, Caroline ;

Harding, Thomas C. ;

Raponi, Mitch ;

Sun, James ;

Lin, Kevin K. ;

Giordano, Heidi ;

Ledermann, Jonathan A. .

LANCET, 2017, 390 (10106) :1949-1961

← 1 2 3 4 5 6 7 →